Literature DB >> 4595311

Mycobacterial cell wall components in tumor suppression and regression.

E E Ribi, T J Meyer, I Azuma, B Zbar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4595311

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  9 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  Immunotherapeutic agents: their role in cellular immunity and their therapeutic potential.

Authors:  M A Chirigos; J E Talmadge
Journal:  Springer Semin Immunopathol       Date:  1985

3.  A rodent carcinoma and its lipidic extracts possess human blood group Tn-, T-, N- and M-specificities.

Authors:  G F Springer; P R Desai; J L Cantrell
Journal:  Naturwissenschaften       Date:  1981-05

4.  Three types of mycolic acid from Mycobacterium tuberculosis Brévanne: implications for structure-function relationships in pathogenesis.

Authors:  R Toubiana; J Berlan; H Sato; M Strain
Journal:  J Bacteriol       Date:  1979-07       Impact factor: 3.490

5.  Mycobacterial ribonucleic acid: comparison with mycobacterial cell wall fractions for regression of murine tumor growth.

Authors:  I Millman; A W Scott; T Halbherr; A S Youmans; G P Youmans
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

6.  Protection of cotton rats against experimental Echinococcus multilocularis infections with BCG cell walls.

Authors:  J M Reuben; C E Tanner; V Portelance
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial.

Authors:  W R Klein; G E Bras; W Misdorp; P A Steerenberg; W H de Jong; R H Tiesjema; A W Kersjes; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; P A Steerenberg; W H De Jong; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

9.  Immunotherapy of a guinea pig hepatoma with mycobacterial vaccines: comparison of BCG cell walls and cell wall skeletons.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.